Search - tctmd.com

Displaying 21 - 40 of 311

Sort: Relevancy | Date

Presentation TCT 2025

TCT 1490: Concomitant Transcatheter Mitral Edge-to-Edge Repair and Left Ventricular Assist Device Therapy in Patients With Acute Decompensated Heart Failure or Cardiogenic Shock and Severe Mitral Regurgitation: A Case Series

Presenter: Michal Kosowski

October 25, 2025

Presentation TCT 2025

A Primer on mTEER in Acute Ichemic Heart Failure: Evidence and Practice

Presenter: Zach Rozenbaum

October 25, 2025

Presentation TCT 2025

Microaxial Flow Pump vs. ECMO in Elective PCI Patients with Ischemic LV Dysfunction: The REC-CHIPMCS Randomized Trial

Presenter: Chao Gao

October 25, 2025

Presentation Interventional Complications 2025

Managing Access-Related Ischemic Complications

Presenter: Saroj Neupane

July 11, 2025

Presentation NY Valves 2025

Transcatheter Aortic Valve Replacement in Systolic Heart Failure and Moderate Aortic Stenosis: Ischemic vs. Non-Ischemic Cardiomyopathy – Insights From the TAVR UNLOAD Trial

Presenter: Philipp von Stein

June 26, 2025

Presentation Fellows 2025

The Role of Coronary Revascularization for Stable Ischemic Heart Disease

Presenter: Ajay J. Kirtane

May 16, 2025

Presentation ACC 2025

Clopidogrel versus Aspirin Monotherapy in Patients with High Ischemic Risk after PCI: SMART-CHOICE 3 Trial

Presenter: Joo-Yong Hahn

March 29, 2025

Presentation THT 2025

Myeloperoxidase Inhibition in Patients With Ischemic or Non-Ischemic Cardiomyopathy and Heart Failure With Reduced Ejection Fraction (MYSTERY-HF)

Presenter: Simon Braumann

February 12, 2025

Presentation AHA 2024

Catheter Ablation or Antiarrhythmic Drug Therapy for Ventricular Tachycardia in Ischemic Cardiomyopathy: The VANISH2 Trial

Presenter: John Sapp

November 16, 2024

Presentation TCT 2024

TCT 102: First-in-Man Experience With the Self-Expandable A-Flux Coronary Sinus Reducer for Treating Symptomatic Ischemic Heart Disease

Presenter: Francesco Giannini

October 30, 2024

Presentation TCT 2024

The Transformation of Diagnosis and Risk Profiling for Ischemic Heart disease: An AI Case Study

Presenter: James Min

October 30, 2024

Presentation TCT 2024

TCT 104: Coronary Hematoma Was a Major Emergent Ischemic Cause After Successful PCI

Presenter: TAKUNORI TSUKUI

October 29, 2024

Presentation TCT 2024

TCT 312: Clinical Predictors of Mortality in Patients With Acute Ischemic Stroke Treated With Mechanical Thrombectomy: A Nonlinear, Internally Validated Model

Presenter: Henriette Mészáros

October 29, 2024

Presentation TCT 2024

TCT 298: Coronary Artery Bypass Grafting Versus Coronary Artery Bypass Grafting Plus Mitral Valve Surgery in Patients With Moderate Ischemic Mitral Regurgitation

Presenter: Abdul Wali Khan

October 29, 2024

Presentation TCT 2024

TCT 254: Importance of Change in LVEF with PCI on Risk of Cardiac Death or Hospitalization for Heart Failure in Pateients With Stable Ischemic Cardiomyopathy

Presenter: Stephen Ellis

October 29, 2024

Presentation TCT 2024

TCT 255: Identifying Patients With Stable Ischemic Cardiomyopathy Whose LVEF Will Increase After PCI

Presenter: Stephen Ellis

October 29, 2024

Presentation TCT 2024

TCT 250: Temporal Trends in Ischemic Heart Disease-related Mortality in Canada Over the Past 3 Decades

Presenter: Ahmed Abdulelah

October 29, 2024

Presentation TCT 2024

Case Presentation: Cardiogenic Shock in a Patient With Non-ischemic Cardiomyopathy

Presenter: Ann Gage

October 29, 2024

Presentation TCT 2024

TCT 792: Prognosis in Patients With Cardiogenic Shock According to Sex, With or Without Ischemic Cardiomyopathy

Presenter: CHANG HOON KIM

October 29, 2024

Presentation TCT 2024

Final Results of the Novel Healing-Targeted DES With Synchronized Antiproliferative Drug Delivery to Target Smooth Muscle Cell Proliferation After DES Implantation in Coronary Artery Disease: 5-Year Results of the PIONEER III Trial

Presenter: Thomas Sharp

October 28, 2024

Advertisement

TCT 1490: Concomitant Transcatheter Mitral Edge-to-Edge Repair and Left Ventricular Assist Device Therapy in Patients With Acute Decompensated Heart Failure or Cardiogenic Shock and Severe Mitral Regurgitation: A Case Series

A Primer on mTEER in Acute Ichemic Heart Failure: Evidence and Practice

Microaxial Flow Pump vs. ECMO in Elective PCI Patients with Ischemic LV Dysfunction: The REC-CHIPMCS Randomized Trial

Managing Access-Related Ischemic Complications

Transcatheter Aortic Valve Replacement in Systolic Heart Failure and Moderate Aortic Stenosis: Ischemic vs. Non-Ischemic Cardiomyopathy – Insights From the TAVR UNLOAD Trial

The Role of Coronary Revascularization for Stable Ischemic Heart Disease

Clopidogrel versus Aspirin Monotherapy in Patients with High Ischemic Risk after PCI: SMART-CHOICE 3 Trial

Myeloperoxidase Inhibition in Patients With Ischemic or Non-Ischemic Cardiomyopathy and Heart Failure With Reduced Ejection Fraction (MYSTERY-HF)

Catheter Ablation or Antiarrhythmic Drug Therapy for Ventricular Tachycardia in Ischemic Cardiomyopathy: The VANISH2 Trial

TCT 102: First-in-Man Experience With the Self-Expandable A-Flux Coronary Sinus Reducer for Treating Symptomatic Ischemic Heart Disease

The Transformation of Diagnosis and Risk Profiling for Ischemic Heart disease: An AI Case Study

TCT 104: Coronary Hematoma Was a Major Emergent Ischemic Cause After Successful PCI

TCT 312: Clinical Predictors of Mortality in Patients With Acute Ischemic Stroke Treated With Mechanical Thrombectomy: A Nonlinear, Internally Validated Model

TCT 298: Coronary Artery Bypass Grafting Versus Coronary Artery Bypass Grafting Plus Mitral Valve Surgery in Patients With Moderate Ischemic Mitral Regurgitation

TCT 254: Importance of Change in LVEF with PCI on Risk of Cardiac Death or Hospitalization for Heart Failure in Pateients With Stable Ischemic Cardiomyopathy

TCT 255: Identifying Patients With Stable Ischemic Cardiomyopathy Whose LVEF Will Increase After PCI

TCT 250: Temporal Trends in Ischemic Heart Disease-related Mortality in Canada Over the Past 3 Decades

Case Presentation: Cardiogenic Shock in a Patient With Non-ischemic Cardiomyopathy

TCT 792: Prognosis in Patients With Cardiogenic Shock According to Sex, With or Without Ischemic Cardiomyopathy

Final Results of the Novel Healing-Targeted DES With Synchronized Antiproliferative Drug Delivery to Target Smooth Muscle Cell Proliferation After DES Implantation in Coronary Artery Disease: 5-Year Results of the PIONEER III Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content